Murdo Gordon

Murdo Gordon has been with Bristol-Myers Squibb for 25 years.  He spent the first 15 years of his career in Canada where he held positions of increasing responsibility in sales and marketing.  Gordon moved to the U.S. in 2003, where he worked in a number of different therapeutic areas such as cardiovascular, neuroscience, access and Government Affairs, as well as oncology and immunology.  He is currently the president of Bristol-Myers Squibb in the U.S. Gordon is a member of the board of directors of Robert Wood Johnson University Hospital System as well as the National Pharmaceutical Council. He maintains an active interest in global and U.S. health care policy and how different stakeholders can improve the efficiency and cost effectiveness of health care delivery. Gordon earned a B.S.c. in cell and molecular biology from Concordia University, Montreal, and also attended the General Management Program, INSEAD-CEDEP, Fontainebleau, France.@bmsnews

More from Murdo Gordon

View more content by Murdo Gordon >>

Subscribe to our eNewsletter